2015
DOI: 10.5935/abc.20150095
|View full text |Cite
|
Sign up to set email alerts
|

High-fat Diet Promotes Cardiac Remodeling in an Experimental Model of Obesity

Abstract: BackgroundAlthough nutritional, metabolic and cardiovascular abnormalities are commonly seen in experimental studies of obesity, it is uncertain whether these effects result from the treatment or from body adiposity.ObjectiveTo evaluate the influence of treatment and body composition on metabolic and cardiovascular aspects in rats receiving high saturated fat diet.MethodsSixteen Wistar rats were used, distributed into two groups, the control (C) group, treated with isocaloric diet (2.93 kcal/g) and an obese (O… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
21
0
3

Year Published

2015
2015
2023
2023

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 29 publications
(24 citation statements)
references
References 30 publications
0
21
0
3
Order By: Relevance
“…In accordance with our echocardiographic results, Lima- observed systolic function improvement in obese rats induced by unsaturated high-fat diet (UHFD) in the period of 30 weeks; authors suggest that the increase in FS and PWSV may be related to decreased after load and improved LV contractility; in addition, Oliveira Junior et al (2013) revealed, in obese rats by UHFD during 20 weeks, improved left ventricular systolic performance assessed by FS. In opposition, studies performed in obesity induced by SHFD (Okere et al 2006;Martins et al 2015) and UHFD (Carroll et al 2006;Okere et al 2006;Medei et al 2010), which vary from 8 to 20 weeks of treatment, showed no functional changes; however, other authors reported cardiac dysfunction in mice fed with UHFD for 20 weeks (Park et al 2005;Cao et al 2016), as well as Relling et al (2006), using obese rats in 12 weeks of treatment with high-fat diet. The papillary muscle results of current investigation showed that obesity did not cause dysfunction when it was evaluated at baseline condition and on stimulation by isoproterenol.…”
Section: Discussionmentioning
confidence: 94%
“…In accordance with our echocardiographic results, Lima- observed systolic function improvement in obese rats induced by unsaturated high-fat diet (UHFD) in the period of 30 weeks; authors suggest that the increase in FS and PWSV may be related to decreased after load and improved LV contractility; in addition, Oliveira Junior et al (2013) revealed, in obese rats by UHFD during 20 weeks, improved left ventricular systolic performance assessed by FS. In opposition, studies performed in obesity induced by SHFD (Okere et al 2006;Martins et al 2015) and UHFD (Carroll et al 2006;Okere et al 2006;Medei et al 2010), which vary from 8 to 20 weeks of treatment, showed no functional changes; however, other authors reported cardiac dysfunction in mice fed with UHFD for 20 weeks (Park et al 2005;Cao et al 2016), as well as Relling et al (2006), using obese rats in 12 weeks of treatment with high-fat diet. The papillary muscle results of current investigation showed that obesity did not cause dysfunction when it was evaluated at baseline condition and on stimulation by isoproterenol.…”
Section: Discussionmentioning
confidence: 94%
“…Although some controversy still exists, an increasing number of studies have highlighted the crucial effects of HFDs on the development of CVD ( 42 , 43 ). For instance, administration of HFDs (20 g of fat/100 g of diet) to adult male rats for 30 days led to simultaneous increase in nitric oxide (NO) production and oxidative stress, causing the augmentation of infarct size after myocardial infarction ( 43 ).…”
Section: Hfd-induced Diseasesmentioning
confidence: 99%
“…Obesity is a factor that worsens the course of hypertension and speeds up the development of changes in the structure of the heart muscle [5,9]. Excess body weight in a certain way also affects the development of geometric remodeling and the emergence of myocardial dysfunction in patients with HT [4,6,8].…”
Section: Introductionmentioning
confidence: 99%